Geffen Residence & Renewal Ltd (TLV:GEFR)
Israel · Delayed Price · Currency is ILS · Price in ILA 84.90
-0.60 (-0.70%)
At close: May 8, 2026
TLV:GEFR Market Cap
TLV:GEFR has a market cap or net worth of 349.26 million as of May 11, 2026. Its market cap has increased by 195.43% in one year.
Market Cap
349.26M
Enterprise Value
419.68M
Revenue
78.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
84.90
Market Cap Chart
Since December 20, 2018, TLV:GEFR's market cap has increased from 29.33M to 349.26M, an increase of 1,090.93%. That is a compound annual growth rate of 39.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 349.26M | 32.80% |
| Dec 31, 2025 | 263.00M | 76.79% |
| Dec 31, 2024 | 148.76M | 47.72% |
| Dec 31, 2023 | 100.70M | 61.09% |
| Dec 29, 2022 | 62.51M | 89.46% |
| Dec 30, 2021 | 33.00M | -64.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 471.93M |
| Matricelf | 91.07M |
| Clal Biotechnology Industries | 53.33M |
| BioLineRx | 41.77M |
| Evogene | 24.91M |
| BioLight Life Sciences | 22.71M |
| Can-Fite BioPharma | 21.30M |
| XTL Biopharmaceuticals | 19.87M |